AMIX Earnings Autonomix Medical, Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–18 of 18
| Q1 2027 | 2026-06-30 | -5.02 | 2026-08-13 | 10-Q |
| Q4 2026 (derived) | 2026-03-31 | 10.51 | 2026-05-27 | 10-K |
| FY 2026 | 2026-03-31 | -48.72 | 2026-05-27 | 10-K |
| Q3 2026 | 2025-12-31 | -7.56 | 2026-02-11 | 10-Q |
| Q2 2026 | 2025-09-30 | -28.98 | 2025-11-12 | 10-Q |
| Q1 2026 | 2025-06-30 | -22.69 | 2025-08-13 | 10-Q |
| Q4 2025 (derived) | 2025-03-31 | -11.13 | 2025-05-29 | 10-K |
| FY 2025 | 2025-03-31 | -135.66 | 2025-05-29 | 10-K |
| Q3 2025 | 2024-12-31 | -30.66 | 2025-02-13 | 10-Q |
| Q2 2024 | 2024-09-30 | -47.67 | 2024-11-08 | 10-Q |
| Q1 2024 | 2024-06-30 | -46.20 | 2024-08-13 | 10-Q |
| Q4 2024 (derived) | 2024-03-31 | -32.97 | 2024-05-31 | 10-K |
| FY 2024 | 2024-03-31 | -311.22 | 2024-05-31 | 10-K |
| Q3 2024 | 2023-12-31 | -96.60 | 2024-02-13 | 10-Q |
| Q2 2023 | 2023-09-30 | -184.38 | — | — |
| Q1 2023 | 2023-06-30 | -29.40 | — | — |
| FY 2023 | 2023-03-31 | -71.40 | — | — |
| Q3 2023 | 2022-12-31 | -21.00 | — | — |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.